No ocular manifestations associated with inflammatory bowel disease, study finds

Article

In a study, investigators found that no characteristics of inflammatory bowel disease are related to ocular manifestations of the disease.

No ocular manifestations associated with inflammatory bowel disease, study finds

Dr Alix Cuny and colleagues from multiple institutions in France and Italy found that no characteristics of inflammatory bowel disease (IBD) are related to ocular manifestations of the disease.

Dr Cuny is from the Department of Ophthalmology, Nancy University Hospital, Nancy, France.

IBD includes ulcerative colitis (UC) and Crohn’s disease (CD), which are chronic disorders that have relapsing and remitting courses.

Because IBD is known for its extra-intestinal manifestations that have been diagnosed in from 19% to 40% of patients, the investigators conducted a retrospective study1 to determine the presence of ocular manifestations of IBD.

After rheumatologic and dermatologic extra-intestinal manifestations, ocular disorders were reported to be the are the third most frequent symptoms,2,3 with uveitis the most frequent, followed by scleritis, episcleritis, and dry eye.

However, the authors noted that ophthalmic manifestations are challenging and because of that may be underreported. They set out to determine if this was the case.

Pinpointing the ocular problems

The study included patients with IBD who had had an ophthalmologic visit from January 2013 to July 2020, among 1432 patients followed during this period. The patients were subdivided into 2 groups; in the first group, the patients had an ocular diagnosis that was considered related to IBD, and in the second group, the patients the ocular diagnosis was thought to be unrelated to IBD.

The analysis found that 87 patients (6.1%) of the 1432 patients with IBD had had an ophthalmologic visit. Of them, 53 patients (3.7%) were considered to have an ocular extra-intestinal manifestation or an iatrogenic effect of IBD treatment, the investigators reported.

The other 34 diagnoses (2.4%) were thought to be unrelated to IBD.

The conditions that were most common were inflammatory surface pathologies (33.2%), which included 15 patients with dry eye (17.2%), 9 with blepharitis (10.3%), and 5 with chalazions (meibomian cysts) (5.7%).

Uveitis was diagnosed in 13 patients (14.9%), episcleritis in 5 patients (5.7%), and scleritis in 2 patients (2.3%). The statistical analysis indicated that the characteristics of patients with an ophthalmologic diagnosis that was considered related to IBD and those unrelated to IBD did not differ significantly.

“Less than 5% of patients had an ophthalmologic extra-intestinal manifestation,” the study concluded. “The most frequent ocular diagnoses were dry eye and uveitis. No disease characteristics of IBD were found to be associated with ocular manifestations.”

References
1. Cuny A, Guillo L, Baumann C, et al. Ocular manifestations in patients with inflammatory bowel disease in the biologics era. J Clin Med.2022;11:4538; https://doi.org/10.3390/jcm11154538
2. Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1982–1992.
3. Zippi M, Corrado C, Pica R, et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol. 2014;20:17463–17467.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.